Cryo Cell International annual return on equity
2021
2022
Cryo Cell International Return on Equity (ROE) Growth & History (CCEL)
Cryo Cell International's return on equity was 208.38% for fiscal 2022.
View full Cryo Cell International company overviewCryo Cell International annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-11-30 | 208.38% | −65.92 pp |
| 2021 | 2021-11-30 | 274.30% | — |
Cryo Cell International quarterly return on equity
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q4.22
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-11-30 | 58.13% | +72.31 pp |
| Q2 2022 | 2022-05-31 | 14.66% | −86.78 pp |
| Q1 2022 | 2022-02-28 | 19.73% | — |
| Q4 2021 | 2021-11-30 | −14.19% | — |
| Q3 2021 | 2021-08-31 | 19.46% | — |
| Q2 2021 | 2021-05-31 | 101.44% | — |
Cryo Cell International return on equity trends
Between the periods ended 2021-11-30 and 2022-11-30, Cryo Cell International's return on equity decreased from 274.30% to 208.38%, a change of −65.92 percentage points. The latest reported quarter, Q4 2022, shows 58.13%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cryo Cell International source filings ↗